Biolase Begins Chapter 11 Bankruptcy, Court-Supervised Sale

MT Newswires Live

Oct 02, 2024

Biolase (BIOL) late Tuesday said it has voluntarily started Chapter 11 bankruptcy proceedings and will seek court approval to remain open for business to complete the sale of its assets.

Under terms of a proposed "stalking horse" transaction, OTC-listed medical device firm Sonendo is offering to pay $14 million in cash for substantially all of Biolase's assets under court supervision. The bid will create a minimum price for the sales process, which may attract other potential buyers.

Biolase also has secured at least $2.5 million in debtor-in-possession financing, including a $1.4 million interim advance, subject to court approval.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2472332445"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2472332445\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2472332445?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-02 05:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2472332445","market":"sh","top_or_hot":-1,"title":"Biolase Begins Chapter 11 Bankruptcy, Court-Supervised Sale","media":"MT Newswires Live","content":"<html><body><p> Biolase (BIOL) late Tuesday said it has voluntarily started Chapter 11 bankruptcy proceedings and will seek court approval to remain open for business to complete the sale of its assets.</p><p>Under terms of a proposed \"stalking horse\" transaction, OTC-listed medical device firm Sonendo is offering to pay $14 million in cash for substantially all of Biolase's assets under court supervision. The bid will create a minimum price for the sales process, which may attract other potential buyers.</p><p>Biolase also has secured at least $2.5 million in debtor-in-possession financing, including a $1.4 million interim advance, subject to court approval.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biolase Begins Chapter 11 Bankruptcy, Court-Supervised Sale</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiolase Begins Chapter 11 Bankruptcy, Court-Supervised Sale\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2024-10-02 05:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Biolase (BIOL) late Tuesday said it has voluntarily started Chapter 11 bankruptcy proceedings and will seek court approval to remain open for business to complete the sale of its assets.</p><p>Under terms of a proposed \"stalking horse\" transaction, OTC-listed medical device firm Sonendo is offering to pay $14 million in cash for substantially all of Biolase's assets under court supervision. The bid will create a minimum price for the sales process, which may attract other potential buyers.</p><p>Biolase also has secured at least $2.5 million in debtor-in-possession financing, including a $1.4 million interim advance, subject to court approval.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BIOL","symbol_name":"Biolase","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2472332445","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2472332445","pubTimestamp":1727817854,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Biolase  late Tuesday said it has voluntarily started Chapter 11 bankruptcy proceedings and will seek court approval to remain open for business to complete the sale of its assets.Under terms of a proposed \"stalking horse\" transaction, OTC-listed medical device firm Sonendo is offering to pay $14 million in cash for substantially all of Biolase's assets under court supervision. The bid will create a minimum price for the sales process, which may attract other potential buyers.Biolase also has secured at least $2.5 million in debtor-in-possession financing, including a $1.4 million interim advance, subject to court approval.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BIOL":"Biolase","BK4082":"医疗保健设备"},"translate_title":"Biolase开始根据美国破产法第11章破产，法院监督出售","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BIOL":1},"content_text":"Biolase (BIOL) late Tuesday said it has voluntarily started Chapter 11 bankruptcy proceedings and will seek court approval to remain open for business to complete the sale of its assets.Under terms of a proposed \"stalking horse\" transaction, OTC-listed medical device firm Sonendo is offering to pay $14 million in cash for substantially all of Biolase's assets under court supervision. The bid will create a minimum price for the sales process, which may attract other potential buyers.Biolase also has secured at least $2.5 million in debtor-in-possession financing, including a $1.4 million interim advance, subject to court approval.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}